USD 0.01
(24.18%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 415.97 Thousand USD | 3592.64% |
2022 | 11.26 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 100.0% |
2019 | -6.00 USD | -101.0% |
2018 | 603.00 USD | 0.0% |
2016 | 603 Thousand USD | 271.3% |
2015 | -352.01 Thousand USD | -139.2% |
2014 | 897.95 Thousand USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q4 | 235.87 Thousand USD | 101.25% |
2023 FY | 415.97 Thousand USD | 3592.64% |
2023 Q3 | 117.2 Thousand USD | 101.28% |
2023 Q1 | 4672.00 USD | 392.31% |
2023 Q2 | 58.22 Thousand USD | 1146.32% |
2022 FY | 11.26 Thousand USD | 0.0% |
2022 Q3 | 9763.00 USD | 1665.46% |
2022 Q4 | 949.00 USD | -90.28% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | 553.00 USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 FY | - USD | 100.0% |
2019 FY | -6.00 USD | -101.0% |
2018 FY | 603.00 USD | 0.0% |
2016 FY | 603 Thousand USD | 271.3% |
2015 FY | -352.01 Thousand USD | -139.2% |
2014 FY | 897.95 Thousand USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Medical Technologies Inc. | 1.69 Million USD | 75.518% |
Ansell Limited | 624.8 Million USD | 99.933% |
Ansell Limited | 624.8 Million USD | 99.933% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 113.94 Million USD | 99.635% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 135.05 Thousand USD | -208.005% |
ConvaTec Group Plc | 1.2 Billion USD | 99.965% |
ConvaTec Group Plc | 1.17 Billion USD | 99.965% |
Encision Inc. | 3.13 Million USD | 86.735% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 794.01 Thousand USD | 47.611% |
LifePoint, Inc. | -71.35 Thousand USD | 682.942% |
Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 417.539% |
Paradigm Medical Industries, Inc. | 525 Thousand USD | 20.766% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 603.24 Thousand USD | 31.043% |
Reflect Scientific, Inc. | 596.42 Thousand USD | 30.255% |
SmileDirectClub, Inc. | 275.84 Million USD | 99.849% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 99.954% |
SheerVision, Inc. | 2.17 Million USD | 80.883% |
United Health Products, Inc. | -4857.00 USD | 8664.464% |
Vasamed, Inc. | -69.38 Thousand USD | 699.493% |
Wearable Health Solutions, Inc. | 267.66 Thousand USD | -55.41% |
Yubo International Biotech Limited | 52.65 Thousand USD | -690.048% |